Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Subsite-resolved molecular and epigenetic characterization of oral tongue squamous cell carcinoma: A systematic review and in silico genome-wide DNA methylation analysis.

Created on 16 Nov 2026

Authors

Bacem Othman, Omid Moztarzadeh, Lukas Hauer

Published in

Dental and medical problems. Volume 63. Issue 5. Pages 1347-1361.

Abstract

Tongue squamous cell carcinoma (TSCC) arises predominantly in a human papillomavirus (HPV)-negative context, which shifts its pathogenesis away from the viral oncogene pathways involved in head and neck cancer.Tongue-attributable literature was systematically reviewed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines, and integrated with a primary genome-wide DNA methylation analysis of 112 SCC samples profiled using Illumina Infinium arrays, with comparisons against normal mucosa and SCCs arising at other head and neck subsites. The reported genes were functionally annotated using PANTHER, consolidated into interpretable thematic clusters, and assessed for evidence of druggability and methodological quality. The findings were synthesized narratively according to the functional theme, with the experimental system specified for each finding.Fifty of the 197 extracted records could be confidently assigned to the tongue, while the remaining 147 were retained as an oral cavity comparator. Tongue SSC was distinguished by methylation and expression markers rather than by PAX5 promoter methylation. Methylation was specifically associated with the tongue, together with a seven-gene expression signature (MTFR1, C8orf33, OTUD6B, NUDCD1, PRKC1, ANO1, and PIK3CA) derived from an HPV-associated comparator set.Tongue SCC diverges from SCCs arising at other oral cavity subsites along an epigenetic rather than a mutational axis. Heterogeneity within TSCC reflects multiple molecular routes converging on a limited number of shared functional endpoints.Limitations of the evidence: Human series were small and mostly retrospective; most study designs were preclinical and therefore provided indirect evidence; HPV, p53 and p16 ascertainment was incomplete; patient-tissue microRNA profiling relied on a single 50-pair series; and no outcomes were reported in a form that permitted data pooling.

PMID:
43037548
Bibliographic data and abstract were imported from PubMed on 16 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement